Dov A. Goldstein - Sep 25, 2024 Form 3 Insider Report for BioAge Labs, Inc. (BIOA)

Role: Chief Financial Officer
Signature: /s/ Dov A. Goldstein
Stock symbol: BIOA
Transactions as of: Sep 25, 2024
Transactions value $: $0
Form type: 3
Date filed: 9/25/2024, 04:45 PM
Previous filing: Jun 26, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	BIOA	Common Stock						22.4K	Sep 25, 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	BIOA	Stock Option (Right to Buy)							Sep 25, 2024	Common Stock	128K	$10.27	Direct	F1
holding	BIOA	Stock Option (Right to Buy)							Sep 25, 2024	Common Stock	120K	$8.39	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option vested as to 1/4th of the total award on November 15, 2022, and thereafter vested or vests as to 1/48th of the total award on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.
F2	The option vested or vests as to 1/48th of the total award monthly, with the first tranche vesting on May 17, 2024, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date. Additionally, the entire award is exercisable at any time pursuant to an early exercise feature of the option award.